Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 28 | 2025 | 342 | 4.260 |
Why?
|
| Respiratory Syncytial Virus, Human | 24 | 2024 | 204 | 4.190 |
Why?
|
| Viral Load | 9 | 2025 | 383 | 1.920 |
Why?
|
| Respiratory Syncytial Viruses | 5 | 2025 | 147 | 0.940 |
Why?
|
| RNA, Viral | 8 | 2024 | 538 | 0.910 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 65 | 0.900 |
Why?
|
| Virus Replication | 6 | 2025 | 608 | 0.870 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 6 | 2025 | 67 | 0.860 |
Why?
|
| Viral Fusion Proteins | 9 | 2023 | 76 | 0.820 |
Why?
|
| Organoids | 2 | 2024 | 282 | 0.790 |
Why?
|
| Antibodies, Viral | 14 | 2025 | 1151 | 0.790 |
Why?
|
| Bacterial Adhesion | 3 | 2007 | 106 | 0.760 |
Why?
|
| Respiratory Tract Infections | 5 | 2022 | 271 | 0.720 |
Why?
|
| Transplant Recipients | 3 | 2021 | 217 | 0.710 |
Why?
|
| Respiratory Mucosa | 3 | 2020 | 91 | 0.650 |
Why?
|
| Cytokines | 2 | 2024 | 1294 | 0.640 |
Why?
|
| Haemophilus influenzae | 4 | 2007 | 130 | 0.630 |
Why?
|
| Influenza, Human | 7 | 2024 | 658 | 0.580 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2021 | 1198 | 0.540 |
Why?
|
| Bronchiolitis | 4 | 2021 | 120 | 0.540 |
Why?
|
| Picornaviridae Infections | 3 | 2024 | 48 | 0.510 |
Why?
|
| Virus Diseases | 4 | 2022 | 280 | 0.510 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 253 | 0.500 |
Why?
|
| Epithelial Cells | 4 | 2024 | 909 | 0.450 |
Why?
|
| Hospitalization | 8 | 2024 | 1777 | 0.430 |
Why?
|
| Enterovirus Infections | 2 | 2024 | 48 | 0.390 |
Why?
|
| Antibodies, Neutralizing | 7 | 2023 | 468 | 0.390 |
Why?
|
| Viruses | 3 | 2024 | 123 | 0.370 |
Why?
|
| Phenotype | 1 | 2021 | 4260 | 0.370 |
Why?
|
| Immunity, Innate | 3 | 2024 | 375 | 0.370 |
Why?
|
| Seasons | 5 | 2024 | 312 | 0.360 |
Why?
|
| Humans | 58 | 2025 | 124955 | 0.350 |
Why?
|
| Influenza A virus | 2 | 2015 | 138 | 0.350 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 71 | 0.350 |
Why?
|
| Sindbis Virus | 1 | 2009 | 9 | 0.330 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2022 | 153 | 0.330 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 503 | 0.320 |
Why?
|
| Adult | 17 | 2025 | 29586 | 0.310 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 141 | 0.310 |
Why?
|
| Virus Shedding | 4 | 2021 | 80 | 0.300 |
Why?
|
| Infant | 16 | 2024 | 12455 | 0.300 |
Why?
|
| Streptococcus pneumoniae | 2 | 2007 | 375 | 0.290 |
Why?
|
| Genome, Viral | 3 | 2024 | 168 | 0.290 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 712 | 0.290 |
Why?
|
| Genotype | 6 | 2021 | 2561 | 0.280 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2006 | 12 | 0.260 |
Why?
|
| Female | 24 | 2025 | 66678 | 0.250 |
Why?
|
| Immunity, Mucosal | 2 | 2025 | 87 | 0.240 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 479 | 0.230 |
Why?
|
| Texas | 5 | 2023 | 3585 | 0.230 |
Why?
|
| Male | 20 | 2025 | 61419 | 0.230 |
Why?
|
| Liposomes | 1 | 2025 | 188 | 0.230 |
Why?
|
| Antigens, Viral | 3 | 2024 | 439 | 0.220 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2024 | 13 | 0.220 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 777 | 0.220 |
Why?
|
| Immunoglobulin A | 2 | 2021 | 208 | 0.220 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 61 | 0.220 |
Why?
|
| Pandemics | 6 | 2024 | 1105 | 0.220 |
Why?
|
| Acetamides | 1 | 2024 | 47 | 0.210 |
Why?
|
| Poliovirus | 1 | 2023 | 47 | 0.210 |
Why?
|
| Enterovirus | 1 | 2024 | 52 | 0.210 |
Why?
|
| Disease Outbreaks | 2 | 2023 | 320 | 0.210 |
Why?
|
| Up-Regulation | 1 | 2006 | 867 | 0.210 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 298 | 0.210 |
Why?
|
| Cell Line | 5 | 2023 | 2758 | 0.200 |
Why?
|
| Lung | 3 | 2025 | 1492 | 0.200 |
Why?
|
| Coinfection | 2 | 2021 | 169 | 0.190 |
Why?
|
| Enterovirus D, Human | 1 | 2021 | 10 | 0.190 |
Why?
|
| Palivizumab | 2 | 2021 | 47 | 0.190 |
Why?
|
| Respiratory Tract Diseases | 1 | 2022 | 75 | 0.190 |
Why?
|
| Viral Structural Proteins | 1 | 2021 | 48 | 0.180 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1327 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 1757 | 0.180 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 38 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 328 | 0.180 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 68 | 0.170 |
Why?
|
| Middle Aged | 7 | 2025 | 26900 | 0.170 |
Why?
|
| Rhinovirus | 2 | 2021 | 59 | 0.170 |
Why?
|
| Haemophilus | 1 | 2019 | 13 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2021 | 388 | 0.160 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 152 | 0.160 |
Why?
|
| Phylogeny | 4 | 2024 | 696 | 0.160 |
Why?
|
| Cities | 3 | 2024 | 47 | 0.160 |
Why?
|
| Orthomyxoviridae | 1 | 2019 | 51 | 0.160 |
Why?
|
| Prospective Studies | 7 | 2024 | 6141 | 0.150 |
Why?
|
| Laboratories | 1 | 2019 | 82 | 0.150 |
Why?
|
| Young Adult | 5 | 2021 | 9039 | 0.150 |
Why?
|
| Child, Preschool | 10 | 2024 | 13987 | 0.150 |
Why?
|
| Cross Infection | 1 | 2021 | 325 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.140 |
Why?
|
| Genes, Viral | 1 | 2017 | 185 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 512 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 450 | 0.130 |
Why?
|
| Child | 12 | 2024 | 24327 | 0.130 |
Why?
|
| CHO Cells | 2 | 2007 | 168 | 0.130 |
Why?
|
| Cricetinae | 2 | 2007 | 422 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2019 | 309 | 0.130 |
Why?
|
| Vaccination | 2 | 2023 | 955 | 0.120 |
Why?
|
| Adolescent | 7 | 2024 | 19316 | 0.120 |
Why?
|
| Influenza B virus | 1 | 2015 | 87 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 357 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 371 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2821 | 0.120 |
Why?
|
| Mutation | 2 | 2024 | 5846 | 0.120 |
Why?
|
| Bodily Secretions | 1 | 2014 | 7 | 0.120 |
Why?
|
| Nasopharynx | 3 | 2019 | 79 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1701 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 62 | 0.110 |
Why?
|
| Aged | 5 | 2021 | 19840 | 0.110 |
Why?
|
| Microbiota | 1 | 2019 | 388 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 178 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 2718 | 0.110 |
Why?
|
| Caspases | 1 | 2014 | 162 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8192 | 0.100 |
Why?
|
| Alphavirus | 1 | 2013 | 17 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 32 | 0.100 |
Why?
|
| Sigmodontinae | 2 | 2025 | 44 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 621 | 0.100 |
Why?
|
| Animals | 8 | 2025 | 34221 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6587 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 293 | 0.100 |
Why?
|
| Cattle | 2 | 2024 | 568 | 0.090 |
Why?
|
| Epidemiological Monitoring | 2 | 2024 | 59 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2021 | 266 | 0.090 |
Why?
|
| Insect Viruses | 1 | 2009 | 9 | 0.080 |
Why?
|
| Organisms, Genetically Modified | 1 | 2009 | 11 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 1585 | 0.080 |
Why?
|
| Disease Vectors | 1 | 2009 | 24 | 0.080 |
Why?
|
| Haemophilus Infections | 2 | 2007 | 91 | 0.080 |
Why?
|
| United States | 5 | 2024 | 10897 | 0.080 |
Why?
|
| Genetic Variation | 3 | 2021 | 1498 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3416 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3893 | 0.080 |
Why?
|
| Molecular Typing | 2 | 2021 | 34 | 0.080 |
Why?
|
| Drosophila | 1 | 2013 | 775 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2006 | 107 | 0.070 |
Why?
|
| Virulence | 2 | 2006 | 262 | 0.070 |
Why?
|
| Cricetulus | 1 | 2007 | 100 | 0.070 |
Why?
|
| Islam | 1 | 2006 | 11 | 0.070 |
Why?
|
| Arabs | 1 | 2006 | 29 | 0.070 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 46 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 1103 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 32 | 0.060 |
Why?
|
| Mucins | 1 | 2006 | 74 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2018 | 834 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2007 | 275 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 132 | 0.060 |
Why?
|
| Livestock | 1 | 2024 | 12 | 0.060 |
Why?
|
| Farmers | 1 | 2024 | 12 | 0.060 |
Why?
|
| Antiviral Agents | 2 | 2022 | 749 | 0.060 |
Why?
|
| Haplotypes | 1 | 2006 | 522 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 229 | 0.060 |
Why?
|
| Influenza in Birds | 1 | 2024 | 27 | 0.060 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 59 | 0.060 |
Why?
|
| Birds | 1 | 2024 | 85 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 766 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 18 | 0.060 |
Why?
|
| Mutation Rate | 1 | 2024 | 66 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2006 | 432 | 0.050 |
Why?
|
| Transfection | 1 | 2006 | 1069 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2006 | 802 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1752 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 293 | 0.050 |
Why?
|
| Bacterial Capsules | 1 | 2003 | 37 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2025 | 383 | 0.050 |
Why?
|
| Pregnancy | 3 | 2022 | 7178 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 357 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2025 | 1003 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 75 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2022 | 29 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3296 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2054 | 0.050 |
Why?
|
| Coronavirus | 1 | 2022 | 25 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2025 | 232 | 0.050 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2023 | 115 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2023 | 124 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 180 | 0.050 |
Why?
|
| Paramyxoviridae Infections | 1 | 2022 | 47 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 44 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2021 | 54 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2024 | 388 | 0.050 |
Why?
|
| Turbinates | 1 | 2021 | 12 | 0.050 |
Why?
|
| Water | 1 | 2023 | 186 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2022 | 28 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2021 | 35 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 370 | 0.050 |
Why?
|
| Fever | 1 | 2024 | 297 | 0.050 |
Why?
|
| Species Specificity | 1 | 2022 | 550 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 1561 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2021 | 211 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 155 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2022 | 141 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 262 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2885 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2024 | 668 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 462 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 2905 | 0.040 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 2020 | 11 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2020 | 39 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3057 | 0.040 |
Why?
|
| Half-Life | 1 | 2020 | 158 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 42 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 251 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 724 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 142 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 84 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 6328 | 0.040 |
Why?
|
| DNA Probes | 1 | 2019 | 123 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 185 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 63 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 737 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2024 | 759 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 1330 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3350 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 191 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 810 | 0.040 |
Why?
|
| DNA Primers | 1 | 2019 | 657 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1291 | 0.040 |
Why?
|
| Chile | 1 | 2017 | 21 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2017 | 39 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1420 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1358 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 2017 | 71 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 90 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 347 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 398 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 244 | 0.030 |
Why?
|
| Nasal Cavity | 1 | 2015 | 50 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 2016 | 145 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 483 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 589 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 142 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4803 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3138 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 229 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1037 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3448 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1060 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2819 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2164 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3721 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 17628 | 0.020 |
Why?
|
| Geography | 1 | 2006 | 113 | 0.020 |
Why?
|
| Asia | 1 | 2006 | 107 | 0.020 |
Why?
|
| India | 1 | 2006 | 214 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1708 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 221 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2006 | 188 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 3084 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 4633 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 2003 | 20 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 215 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1437 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10282 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 167 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 477 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 16303 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 889 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 2448 | 0.010 |
Why?
|